Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Bolen

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|May 23, 2023
Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimenCamille Laurent, Maria Flores, Loïc Chartier, et al.
Frontiers in Immunology|October 18, 2019
Increased T Cell Differentiation and Cytolytic Function in Bangladeshi Compared to American ChildrenLisa E Wagar, Christopher R Bolen, Natalia Sigal, et al.
Blood Advances|January 4, 2018
Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsetsChristopher R Bolen, Ronald McCord, Sarah Huet, et al.
Haematologica|October 15, 2020
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA studyChristopher R Bolen, Magdalena Klanova, Marek Trneny, et al.
Nature Communications|March 24, 2016
Individual heritable differences result in unique cell lymphocyte receptor repertoires of naïve and antigen-experienced cellsFlorian Rubelt, Christopher R Bolen, Helen M McGuire, et al.
Ejhaem|July 18, 2022
A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYALale Kostakoglu, Federico Dalmasso, Paola Berchialla, et al.
Blood Advances|December 23, 2021
Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphomaAnn-Marie E Bröske, Koorosh Korfi, Anton Belousov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of AtezolizumabOmid Hamid, Luciana Molinero, Christopher R Bolen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2017
Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep SequencingJason A Vander Heiden, Panos Stathopoulos, Julian Q Zhou, et al.
Frontiers in Oncology|August 23, 2021
Decoupling Lineage-Associated Genes in Acute Myeloid Leukemia Reveals Inflammatory and Metabolic Signatures Associated With OutcomesHussein A Abbas, Vakul Mohanty, Ruiping Wang, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|May 23, 2023
Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimenCamille Laurent, Maria Flores, Loïc Chartier, et al.
Frontiers in Immunology|October 18, 2019
Increased T Cell Differentiation and Cytolytic Function in Bangladeshi Compared to American ChildrenLisa E Wagar, Christopher R Bolen, Natalia Sigal, et al.
Blood Advances|January 4, 2018
Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsetsChristopher R Bolen, Ronald McCord, Sarah Huet, et al.
Haematologica|October 15, 2020
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA studyChristopher R Bolen, Magdalena Klanova, Marek Trneny, et al.
Nature Communications|March 24, 2016
Individual heritable differences result in unique cell lymphocyte receptor repertoires of naïve and antigen-experienced cellsFlorian Rubelt, Christopher R Bolen, Helen M McGuire, et al.
Ejhaem|July 18, 2022
A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYALale Kostakoglu, Federico Dalmasso, Paola Berchialla, et al.
Blood Advances|December 23, 2021
Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphomaAnn-Marie E Bröske, Koorosh Korfi, Anton Belousov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of AtezolizumabOmid Hamid, Luciana Molinero, Christopher R Bolen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2017
Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep SequencingJason A Vander Heiden, Panos Stathopoulos, Julian Q Zhou, et al.
Frontiers in Oncology|August 23, 2021
Decoupling Lineage-Associated Genes in Acute Myeloid Leukemia Reveals Inflammatory and Metabolic Signatures Associated With OutcomesHussein A Abbas, Vakul Mohanty, Ruiping Wang, et al.
Pageof 5